H-One Cream contains Hydroquinone 4% w/w, a topical depigmenting agent indicated for the treatment of hyperpigmentation disorders such as melasma, freckles, age spots, and post-inflammatory hyperpigmentation. Hydroquinone acts by inhibiting the enzyme tyrosinase, which plays a crucial role in the synthesis of melanin, thereby reducing the production and accumulation of pigment in the skin. This cream is intended for external use only and should be applied sparingly to the affected areas once or twice daily as directed by a healthcare professional. Patients are advised to avoid excessive sun exposure and to use broad-spectrum sunscreen during treatment to prevent further pigmentation and protect sensitive skin. Common side effects may include mild irritation, redness, or dryness at the application site; if severe irritation or allergic reactions occur, use should be discontinued and medical advice sought. H-One Cream is contraindicated in individuals with known hypersensitivity to hydroquinone or any of the formulation components. It is not recommended for use during pregnancy or lactation due to limited safety data. Consistent application over several weeks is necessary to observe clinical improvement, and treatment duration should be limited to minimize the risk of ochronosis or other adverse effects.